Mitochondria-SR interaction and mitochondrial fusion/fission in the regulation of skeletal muscle metabolism.


Journal

Metabolism: clinical and experimental
ISSN: 1532-8600
Titre abrégé: Metabolism
Pays: United States
ID NLM: 0375267

Informations de publication

Date de publication:
07 2023
Historique:
received: 24 11 2022
revised: 20 03 2023
accepted: 22 04 2023
medline: 20 6 2023
pubmed: 11 5 2023
entrez: 10 5 2023
Statut: ppublish

Résumé

Mitochondria-endoplasmic/sarcoplasmic reticulum (ER/SR) interaction and mitochondrial fusion/fission are critical processes that influence substrate oxidation. This narrative review summarizes the evidence on the effects of substrate availability on mitochondrial-SR interaction and mitochondria fusion/fission dynamics to modulate substrate oxidation in human skeletal muscle. Evidence shows that an increase in mitochondria-SR interaction and mitochondrial fusion are associated with elevated fatty acid oxidation. In contrast, a decrease in mitochondria-SR interaction and an increase in mitochondrial fission are associated with an elevated glycolytic activity. Based on the evidence reviewed, we postulate two hypotheses for the link between mitochondrial dynamics and insulin resistance in human skeletal muscle. First, glucose and fatty acid availability modifies mitochondria-SR interaction and mitochondrial fusion/fission to help the cell to adapt substrate oxidation appropriately. Individuals with an impaired response to these substrate challenges will accumulate lipid species and develop insulin resistance in skeletal muscle. Second, a chronically elevated substrate availability (e.g. overfeeding) increases mitochondrial production of reactive oxygen species and induced mitochondrial fission. This decreases fatty acid oxidation, thus leading to the accumulation of lipid species and insulin resistance in skeletal muscle. Altogether, we propose mitochondrial dynamics as a potential target for disturbances associated with low fatty acid oxidation.

Identifiants

pubmed: 37164310
pii: S0026-0495(23)00181-6
doi: 10.1016/j.metabol.2023.155578
pii:
doi:

Substances chimiques

Fatty Acids 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

155578

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare no competing interests.

Auteurs

Mauricio Castro-Sepulveda (M)

Laboratorio de Fisiología del Ejercicio y Metabolismo (LABFEM), Escuela de Kinesiologia, Facultad de Medicina, Universidad Finis Terrae, Santiago, Chile. Electronic address: mcastro@uft.cl.

Rodrigo Fernández-Verdejo (R)

Laboratorio de Fisiología del Ejercicio y Metabolismo (LABFEM), Escuela de Kinesiologia, Facultad de Medicina, Universidad Finis Terrae, Santiago, Chile.

Hermann Zbinden-Foncea (H)

Laboratorio de Fisiología del Ejercicio y Metabolismo (LABFEM), Escuela de Kinesiologia, Facultad de Medicina, Universidad Finis Terrae, Santiago, Chile; Centro de Salud Deportiva, Clinica Santa Maria, Santiago, Chile.

Jennifer Rieusset (J)

CarMeN Laboratory, UMR INSERM U1060/INRA U1397, Université Claude Bernard Lyon 1, Pierre-Bénite, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH